Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jun-2026 00:15 ET (19-Jun-2026 04:15 GMT/UTC)
Zinc oxide nanoparticles are widely incorporated into sunscreens, cosmetics, and topical formulations, yet their biological effects may change under microbe-rich skin conditions. This study shows that co-exposure to ZnO nanoparticles and Staphylococcus aureus markedly aggravates injury in HaCaT keratinocytes. ZnO-induced reactive oxygen species disrupt barrier integrity, impair mitochondrial function, activate apoptotic signaling, and promote inflammatory responses. The presence of S. aureus further amplifies these effects, partly through MAPK pathway activation. These findings highlight the need to evaluate nanomaterial safety in realistic skin microenvironment settings, especially for inflamed or barrier-impaired skin and products intended for daily use.
A humanitarian medical delegation of senior physicians and medical students has begun operating in Kenya as part of the “Humanitarian Elective,” an initiative focused on supporting local healthcare teams while providing participants with immersive clinical experience in resource-limited settings. Through hands-on work in emergency and pediatric medicine, students are learning to navigate medical crises, healthcare inequality, cultural differences, and severe shortages of equipment and infrastructure. Organizers hope the program will help shape a new generation of globally minded physicians and establish humanitarian medicine as a natural part of medical training.
Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study which could help pave the way for more personalised treatments for sarcopenia in people with end‑stage liver disease.
The research was led by scientists at the University of Birmingham, published in the Journal of Cachexia, Sarcopenia and Muscle and delivered through the National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC): Birmingham. The study reveals for the first time that the underlying cause of liver disease shapes how muscle loss develops and how it may respond to treatment.